2.16
price down icon6.49%   -0.15
after-market 시간 외 거래: 2.12 -0.04 -1.85%
loading
전일 마감가:
$2.31
열려 있는:
$2.375
하루 거래량:
2.02M
Relative Volume:
0.91
시가총액:
$94.15M
수익:
$16.77M
순이익/손실:
$-11.87M
주가수익비율:
-4.555
EPS:
-0.4742
순현금흐름:
$-5.90M
1주 성능:
+24.86%
1개월 성능:
+131.69%
6개월 성능:
+274.67%
1년 성능:
+158.99%
1일 변동 폭
Value
$2.00
$2.41
1주일 범위
Value
$1.61
$2.41
52주 변동 폭
Value
$0.30
$2.41

Immunoprecise Antibodies Ltd Stock (IPA) Company Profile

Name
명칭
Immunoprecise Antibodies Ltd
Name
전화
-
Name
주소
-
Name
직원
101
Name
트위터
Name
다음 수익 날짜
2024-09-16
Name
최신 SEC 제출 서류
Name
IPA's Discussions on Twitter

IPA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IPA
Immunoprecise Antibodies Ltd
2.16 83.29M 16.77M -11.87M -5.90M -0.4742
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 122.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 31.91B 3.81B -644.79M -669.77M -6.24

Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-12-02 개시 H.C. Wainwright Buy
2021-10-25 개시 The Benchmark Company Buy

Immunoprecise Antibodies Ltd 주식(IPA)의 최신 뉴스

pulisher
09:49 AM

Is ImmunoPrecise Antibodies Ltd. a good long term investmentMarket-leading profit generation - PrintWeekIndia

09:49 AM
pulisher
Jul 24, 2025

IPA’s Stock Market Labyrinth: Navigating 2025’s Gains and Declines - investchronicle.com

Jul 24, 2025
pulisher
Jul 24, 2025

ImmunoPrecise Unveils Breakthrough in Predicting Drug Antibody Risks - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

ImmunoPrecise Releases New Findings Showing LENSai™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the Clinic - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

What drives ImmunoPrecise Antibodies Ltd. stock priceDynamic portfolio growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about ImmunoPrecise Antibodies Ltd. stockFree Predictions - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

ImmunoPrecise Antibodies Ltd. Stock Analysis and ForecastRapid portfolio appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

ImmunoPrecise Strengthens Advisory Board with AI Expert Jeff Fried - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

ImmunoPrecise Antibodies (OTCMKTS:IPATF) Stock Price Down 0.6% – What’s Next? - Defense World

Jul 22, 2025
pulisher
Jul 21, 2025

ImmunoPrecise Antibodies appoints data expert Jeff Fried to advisory board - Investing.com Australia

Jul 21, 2025
pulisher
Jul 21, 2025

ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board - Yahoo Finance

Jul 21, 2025
pulisher
Jul 20, 2025

Is ImmunoPrecise Antibodies Ltd. stock a good hedge against inflationFree Investment Portfolio Suggestions - beatles.ru

Jul 20, 2025
pulisher
Jul 16, 2025

why immunoprecise antibodies ltd. stock attracts strong analyst attentionMarket Beating Strategy - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025 - 01net

Jul 16, 2025
pulisher
Jul 16, 2025

ImmunoPrecise Antibodies to Announce Q4 and FY 2025 Results - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

Why ImmunoPrecise Antibodies Ltd. stock attracts strong analyst attentionElite Stock Shortlist - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How ImmunoPrecise Antibodies Ltd. stock performs during market volatilityShort Squeeze Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Tech Momentum Surges as IPA, HIT, SNYR, PNPN.V, KAPA and Others Drive Investor Awareness – More Stocks Inside - FinancialContent

Jul 15, 2025
pulisher
Jul 15, 2025

What makes ImmunoPrecise Antibodies Ltd. stock price move sharplyFree Risk Assessment Services - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

ImmunoPrecise Regains Nasdaq Compliance, Strengthening Market Position - The Globe and Mail

Jul 15, 2025
pulisher
Jul 15, 2025

ImmunoPrecise regains Nasdaq compliance as share price stabilizes By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 14, 2025

ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement - 01net

Jul 14, 2025
pulisher
Jul 14, 2025

ImmunoPrecise Antibodies Ltd Inc. (IPA) Price Performance: The Role of Share Buybacks and Stock Splits - investchronicle.com

Jul 14, 2025
pulisher
Jul 14, 2025

ImmunoPrecise regains Nasdaq compliance as share price stabilizes - Investing.com

Jul 14, 2025
pulisher
Jul 07, 2025

ImmunoPrecise Antibodies Appoints Jon Lieber to Board of Directors - citybiz

Jul 07, 2025
pulisher
Jul 07, 2025

ImmunoPrecise Antibodies Strengthens Board with Industry Veteran Jon Lieber - TipRanks

Jul 07, 2025
pulisher
Jul 07, 2025

ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors - New Castle News

Jul 07, 2025
pulisher
Jul 06, 2025

ImmunoPrecise Antibodies’ LENSai Platform Achieves Breakthrough in Epitope Mapping Accuracy - Insider Monkey

Jul 06, 2025
pulisher
Jul 03, 2025

ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data - 01net

Jul 03, 2025
pulisher
Jul 03, 2025

ImmunoPrecise Antibodies Skyrockets: AI-Powered Drug Discovery Takes Center Stage - RagingBull

Jul 03, 2025
pulisher
Jul 03, 2025

ImmunoPrecise’s LENSai Platform Achieves Breakthrough in Antibody Binding Prediction - TipRanks

Jul 03, 2025

Immunoprecise Antibodies Ltd (IPA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):